Companies: 10,795·Total market cap: $144.5T
BioELife Corp.

BioELife Corp.

LITHOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$941
P/E Ratio—
52W High$0.0002
52W Low$0.000001
Overview

BioELife Corp. (LITH) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

LITH · cash on hand · updated Dec 31, 2018

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$124,941▲ +25398.2% vs prior year
FY · as of Dec 31, 2018 · Reported in USD
Cash & Cash Equiv. (CCE)
$4,065
cashAndCashEquivalents
Short-Term Investments
$120,876
shortTermInvestments
YoY Change vs Prior Year
+25398.2%
vs prior fiscal year
Latest Quarter
$22,247
Q3 2019
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2018

Net cash vs debt

Cash & ST Investments$124,941Cash on Hand
Total Debt$279,563Total Debt
Net Cash / Net Debt−$154,622Net Debt Position
Cash vs Debt Ratio
Cash 31%Debt 69%

BioELife Corp. carries a net debt position of $154,622. Total debt ($279,563) exceeds cash on hand ($124,941). BioELife Corp. cash vs debt ratio: 31% cash / 69% debt.

Net Cash = Cash & ST Investments − Total Debt$124,941 − $279,563 = −$154,622

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
LITH annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2018Latest$0.1M+25398.2%
Dec 31, 2017$0.0M-93.5%
Dec 31, 2016$0.0M+442.8%
Dec 31, 2015$0.0M+442.6%
Dec 31, 2014$0.0M-94.3%
LITH cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
BioELife Corp.
BioELife Corp.YOU
LITH
$0.1M13277.5%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

BioELife Corp. (LITH) cash on hand as of December 31, 2018 is $124,941, comprising $4,065 in cash and cash equivalents (CCE) plus $120,876 in short-term investments — reported as BioELife Corp. cash and short-term investments on the balance sheet (10-K filing). Also referred to as BioELife Corp. cash reserves or cash position.

BioELife Corp. annual cash on hand history shows increased +25398.2% in 2018: increased +25398.2% in 2018. BioELife Corp. cash reserves in 2018 reflect the company's capital allocation strategy.

BioELife Corp. carries total debt of $279,563 against cash of $124,941, resulting in a net debt position of -$154,622. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

LITH cash on hand · 5 questions

As of December 31, 2018, BioELife Corp. (LITH) has $124,941 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $4,065 in cash and cash equivalents (CCE) plus $120,876 in short-term investments. Latest quarter (September 30, 2019): $22,247. Data sourced from the annual 10-K filing via FMP.

LITH cash on handLITH cash reservesLITH cash 2018how much cash does LITH have

▸ Source: FMP /balance-sheet-statement · US GAAP · BioELife Corp. · BioELife Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2018